An exciting time for NAD research: An interview with Dr. Susan Broom Gibson

Susan Broom Gibson, PhD, is an associate professor of psychology, School of Natural and Behavioral Sciences, William Carey University, in Hattiesburg, MS, a research consultant for Springfield Wellness Center, and co-chairs the advisory board of NAD Research, Inc. She received her PhD in experimental psychology from the University of Mississippi in 2002 and completed research associate/fellowship positions at Boston University School of Medicine and Tulane University School of Medicine. Her areas of specialty include: the neuro-mechanisms of drug abuse and withdrawal, animal models of drug abuse and stress, and alternative treatment for substance use disorders. 

Over the past 15 years she has conducted research in the therapeutic potential of IV administration of NAD for the treatment of acute withdrawal symptoms associated with substance use disorders and Parkinson’s, and in the therapeutic potential of intranasal (sphenocatheter) administration of NAD for migraines and the maintenance of symptoms associated with Parkinson’s Disease. She spoke with us via Zoom in March 2023. 

Continue reading

Utilizing light to optimize intravenous NAD effectiveness

An interview with Michael Payne, MS, CRC, CNS

Michael Payne is perhaps the world’s leading specialist in the field of photobiomodulation therapy (PBMT) and NAD supplementation.

PBMT utilizes non-ionizing forms of light (including LASERS, LEDs, and broadband light) in the visible and near infrared spectrum. Without involving heat, it activates endogenous chromophores to begin photophysical and photochemical processes.

There are numerous examples of light-induced photochemical reactions in biological systems. Vision, for example, results when light interacts with photosensitive cells in our retinas, which convert light energy into electrical signals that are transmitted to the visual processing centers of the brain. Similarly, our skin produces vitamin D as a result of sunlight activating a form of cholesterol, 7-dehydrocholesterol, converting it to vitamin D3. The negative effects of the absence of light on the human body are also well known. Two examples include seasonal affective disorder (SAD) and lack of vitamin D production leading to rickets.

Continue readingUtilizing light to optimize intravenous NAD effectiveness

In a nutshell: summarizing our current knowledge of NAD and where we go next

An interview with Dr. Ross Grant

Dr. Ross Grant

Dr. Ross Grant is a biochemical pharmacologist and CEO of the Australasian Research Institute at Sydney Adventist Hospital. Dr. Grant has co-authored more than 100 academic articles in his research area, which focuses on understanding how a person’s lifestyle factors change their body’s biochemistry and immune activity, driving it toward either health or disease. In particular, he is interested in the influence of lifestyle factors on natural killer (NK) cell activity, redox balance (oxidative stress), and NAD+ metabolism, and how these influence cellular degeneration, particularly in the brain and central nervous system. He is a member of the Australian Neuroscience society (ANS), Nutrition Society of Australia (NSA), Australasian Society of Lifestyle Medicine, serves on the Advisory Board of NAD Research, Inc., and is one of our primary research partners.

Continue readingIn a nutshell: summarizing our current knowledge of NAD and where we go next